Device Trial Radar · NCT00206856
Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)
Last checked: Nov 20, 2026Latest source record: Jul 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Abbott RDx CardiometabolicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 21, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine the clinical utility of using the Triage® BNP Test to guide therapy in outpatients with heart failure
Conditions
- Heart Failure
Interventions
Triage® B-Type Natriuretic Peptide (BNP) TestDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Combined endpoint of mortality, unplanned clinic or hospital visits that require IV treatment for heart failure, and quality of life.
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Scottsdale CardiovascularResearch
Scottsdale, Arizona
28 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.